Waylivra▼® (volanesorsen), the first and only therapy for fcs, an ultra-rare and life-threatening condition, to be available on the nhs in england

Akcea therapeutics uk ltd., a subsidiary of akcea therapeutics inc. (nasdaq: akca), announced today that the national institute for health and care ex

AP Ratings Summary

AP Quant Ranking